The argument for diversifying the NIH grant portfolio.
Mol Biol Cell. 2017 Nov 1;28(22):2935-2940. doi: 10.1091/mbc.E17-07-0462.
Mol Biol Cell. 2017.
PMID: 29084912
Free PMC article.
The United States has been a leader in biomedical science for decades, in large part because of the strategy used by the National Institutes of Health (NIH) to invest its budgetary portfolio. They identified talented young scientists from each generati …
The United States has been a leader in biomedical science for decades, in large part because of the strategy used by the National …